Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Nicotinic | 21 | 2016 | 494 | 1.800 |
Why?
|
Nicotinic Agonists | 13 | 2016 | 266 | 1.230 |
Why?
|
Behavior, Animal | 18 | 2022 | 1865 | 0.900 |
Why?
|
Motor Activity | 13 | 2019 | 2704 | 0.760 |
Why?
|
Antidepressive Agents | 12 | 2016 | 2897 | 0.710 |
Why?
|
Azetidines | 6 | 2014 | 150 | 0.670 |
Why?
|
Nicotine | 8 | 2008 | 682 | 0.520 |
Why?
|
Neurotransmitter Uptake Inhibitors | 2 | 2010 | 36 | 0.440 |
Why?
|
Amitriptyline | 2 | 2004 | 109 | 0.440 |
Why?
|
Rodentia | 1 | 2014 | 261 | 0.420 |
Why?
|
Quinoxalines | 2 | 2011 | 296 | 0.390 |
Why?
|
Benzazepines | 2 | 2011 | 308 | 0.390 |
Why?
|
Fear | 11 | 2024 | 1499 | 0.390 |
Why?
|
Antidepressive Agents, Tricyclic | 2 | 2004 | 426 | 0.390 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2011 | 414 | 0.380 |
Why?
|
Gamma Rays | 2 | 2024 | 324 | 0.380 |
Why?
|
CLOCK Proteins | 1 | 2011 | 88 | 0.360 |
Why?
|
Iron Radioisotopes | 2 | 2021 | 19 | 0.360 |
Why?
|
Alzheimer Disease | 9 | 2024 | 8730 | 0.350 |
Why?
|
Helplessness, Learned | 4 | 2004 | 25 | 0.320 |
Why?
|
Cyclopropanes | 3 | 2017 | 437 | 0.310 |
Why?
|
Pyridines | 5 | 2011 | 2888 | 0.310 |
Why?
|
Sex Characteristics | 6 | 2024 | 2643 | 0.310 |
Why?
|
Mice, Inbred C57BL | 24 | 2024 | 22332 | 0.300 |
Why?
|
Locomotion | 1 | 2010 | 384 | 0.290 |
Why?
|
Alzheimer Vaccines | 2 | 2020 | 25 | 0.290 |
Why?
|
Presenilin-1 | 3 | 2021 | 665 | 0.280 |
Why?
|
Mice | 48 | 2024 | 81819 | 0.280 |
Why?
|
Hippocampus | 7 | 2023 | 3775 | 0.270 |
Why?
|
Drug Discovery | 1 | 2014 | 1064 | 0.270 |
Why?
|
Swimming | 4 | 2011 | 212 | 0.270 |
Why?
|
Antipsychotic Agents | 4 | 2017 | 3076 | 0.260 |
Why?
|
Animals | 67 | 2024 | 168764 | 0.260 |
Why?
|
Morphine | 4 | 2001 | 660 | 0.240 |
Why?
|
Mice, Knockout | 21 | 2024 | 14448 | 0.240 |
Why?
|
Mice, Transgenic | 10 | 2024 | 9550 | 0.240 |
Why?
|
Anxiety | 4 | 2019 | 4671 | 0.240 |
Why?
|
Complement C3 | 2 | 2017 | 424 | 0.230 |
Why?
|
Cosmic Radiation | 1 | 2024 | 24 | 0.230 |
Why?
|
Plaque, Amyloid | 3 | 2021 | 772 | 0.230 |
Why?
|
Disease Models, Animal | 10 | 2024 | 18293 | 0.220 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 2 | 2017 | 30 | 0.220 |
Why?
|
Hindlimb Suspension | 4 | 2010 | 77 | 0.210 |
Why?
|
Pyrrolidonecarboxylic Acid | 3 | 2021 | 66 | 0.210 |
Why?
|
Benzhydryl Compounds | 1 | 2010 | 939 | 0.210 |
Why?
|
Wakefulness | 1 | 2010 | 1282 | 0.200 |
Why?
|
Methylamines | 2 | 2017 | 136 | 0.200 |
Why?
|
Cocaine | 4 | 2010 | 946 | 0.200 |
Why?
|
Structure-Activity Relationship | 9 | 2017 | 3051 | 0.200 |
Why?
|
Central Nervous System Stimulants | 2 | 2010 | 1167 | 0.200 |
Why?
|
Islet Amyloid Polypeptide | 1 | 2021 | 41 | 0.190 |
Why?
|
Piperidines | 1 | 2010 | 1664 | 0.190 |
Why?
|
Amyloid beta-Peptides | 6 | 2024 | 3896 | 0.190 |
Why?
|
Conditioning, Classical | 5 | 2005 | 368 | 0.190 |
Why?
|
alpha-Synuclein | 2 | 2018 | 772 | 0.180 |
Why?
|
RGS Proteins | 2 | 2013 | 75 | 0.180 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2011 | 10729 | 0.180 |
Why?
|
Dementia, Vascular | 1 | 2021 | 126 | 0.170 |
Why?
|
Isoxazoles | 2 | 2012 | 234 | 0.170 |
Why?
|
Mice, Inbred BALB C | 7 | 2019 | 6220 | 0.170 |
Why?
|
Maze Learning | 5 | 2024 | 482 | 0.160 |
Why?
|
Nicotinic Antagonists | 4 | 2014 | 90 | 0.160 |
Why?
|
Socialization | 1 | 2019 | 87 | 0.160 |
Why?
|
Brain | 12 | 2024 | 27171 | 0.160 |
Why?
|
Drug Partial Agonism | 4 | 2012 | 24 | 0.160 |
Why?
|
Anti-Anxiety Agents | 1 | 2021 | 402 | 0.160 |
Why?
|
Ligands | 7 | 2017 | 3273 | 0.160 |
Why?
|
tau Proteins | 3 | 2021 | 2112 | 0.150 |
Why?
|
Brain Chemistry | 1 | 2002 | 952 | 0.150 |
Why?
|
Electroshock | 7 | 2005 | 120 | 0.150 |
Why?
|
Rats | 16 | 2021 | 23707 | 0.150 |
Why?
|
Rats, Sprague-Dawley | 11 | 2010 | 8102 | 0.150 |
Why?
|
Freezing Reaction, Cataleptic | 2 | 2016 | 40 | 0.150 |
Why?
|
Urination | 1 | 2019 | 204 | 0.150 |
Why?
|
Association Learning | 3 | 2006 | 219 | 0.140 |
Why?
|
Physical Conditioning, Animal | 1 | 2021 | 366 | 0.140 |
Why?
|
Fibronectins | 1 | 2021 | 719 | 0.140 |
Why?
|
Receptors, GABA-A | 1 | 2022 | 624 | 0.140 |
Why?
|
Receptor, Serotonin, 5-HT2C | 1 | 2017 | 41 | 0.140 |
Why?
|
Larva | 2 | 2016 | 511 | 0.140 |
Why?
|
Hormones | 1 | 2021 | 863 | 0.140 |
Why?
|
Reflex | 1 | 2019 | 376 | 0.140 |
Why?
|
Immunization, Passive | 2 | 2020 | 616 | 0.140 |
Why?
|
Neurons | 7 | 2018 | 9525 | 0.140 |
Why?
|
Dopamine Uptake Inhibitors | 2 | 2010 | 287 | 0.140 |
Why?
|
Memory | 3 | 2024 | 2190 | 0.130 |
Why?
|
Seizures | 2 | 2022 | 3000 | 0.130 |
Why?
|
Space Flight | 1 | 2019 | 219 | 0.130 |
Why?
|
Bipolar Disorder | 2 | 2011 | 5138 | 0.130 |
Why?
|
Depression | 5 | 2014 | 8237 | 0.130 |
Why?
|
Tobacco Use Disorder | 1 | 2002 | 708 | 0.130 |
Why?
|
Escape Reaction | 1 | 2016 | 57 | 0.130 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2017 | 216 | 0.130 |
Why?
|
Benzylamines | 1 | 2017 | 251 | 0.130 |
Why?
|
Receptors, sigma | 1 | 2016 | 33 | 0.130 |
Why?
|
Mecamylamine | 2 | 2006 | 27 | 0.130 |
Why?
|
Molecular Structure | 4 | 2016 | 1885 | 0.130 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2021 | 1116 | 0.130 |
Why?
|
Antibodies, Monoclonal | 3 | 2020 | 9249 | 0.130 |
Why?
|
Microglia | 2 | 2022 | 1372 | 0.120 |
Why?
|
Parkinsonian Disorders | 1 | 2018 | 286 | 0.120 |
Why?
|
Neurosciences | 1 | 2019 | 385 | 0.120 |
Why?
|
Synaptosomes | 2 | 2015 | 116 | 0.120 |
Why?
|
Stress, Physiological | 1 | 2002 | 1402 | 0.120 |
Why?
|
Cognition | 4 | 2021 | 7049 | 0.120 |
Why?
|
Apyrase | 1 | 2017 | 373 | 0.120 |
Why?
|
Stereoisomerism | 5 | 2017 | 614 | 0.120 |
Why?
|
Zebrafish | 2 | 2016 | 3036 | 0.120 |
Why?
|
Nerve Degeneration | 2 | 2017 | 748 | 0.110 |
Why?
|
Dopamine | 3 | 2010 | 1582 | 0.110 |
Why?
|
Pain Threshold | 3 | 1996 | 604 | 0.110 |
Why?
|
Substance-Related Disorders | 2 | 2010 | 4416 | 0.110 |
Why?
|
Neuroglia | 1 | 2020 | 964 | 0.110 |
Why?
|
Organ Transplantation | 1 | 2023 | 1174 | 0.110 |
Why?
|
Avoidance Learning | 4 | 2005 | 248 | 0.110 |
Why?
|
Social Behavior | 1 | 2019 | 1146 | 0.100 |
Why?
|
Analgesia | 1 | 1997 | 461 | 0.100 |
Why?
|
Adenosine | 1 | 2017 | 806 | 0.100 |
Why?
|
Aging | 5 | 2023 | 8731 | 0.100 |
Why?
|
Male | 39 | 2024 | 363698 | 0.100 |
Why?
|
Amygdala | 1 | 2019 | 1377 | 0.090 |
Why?
|
Analysis of Variance | 3 | 2008 | 6203 | 0.090 |
Why?
|
Heart | 1 | 2024 | 4414 | 0.090 |
Why?
|
Adenosine Triphosphate | 1 | 2017 | 1999 | 0.090 |
Why?
|
Mice, Inbred A | 1 | 2010 | 244 | 0.090 |
Why?
|
Aza Compounds | 1 | 2010 | 34 | 0.090 |
Why?
|
Small Molecule Libraries | 1 | 2016 | 741 | 0.090 |
Why?
|
Radioligand Assay | 4 | 2012 | 364 | 0.090 |
Why?
|
Depressive Disorder | 1 | 2003 | 3714 | 0.090 |
Why?
|
Mice, Mutant Strains | 2 | 2011 | 1745 | 0.090 |
Why?
|
Nociceptors | 1 | 1994 | 465 | 0.090 |
Why?
|
Biogenic Monoamines | 1 | 2010 | 50 | 0.090 |
Why?
|
Tranylcypromine | 1 | 2009 | 30 | 0.080 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2023 | 869 | 0.080 |
Why?
|
Chromosome Mapping | 1 | 1997 | 4618 | 0.080 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2010 | 187 | 0.080 |
Why?
|
Kidney | 1 | 2024 | 7066 | 0.080 |
Why?
|
Cell Proliferation | 1 | 2004 | 10429 | 0.080 |
Why?
|
GTP-Binding Proteins | 1 | 2013 | 945 | 0.080 |
Why?
|
Time Factors | 5 | 2021 | 40065 | 0.080 |
Why?
|
Substance Withdrawal Syndrome | 3 | 2010 | 624 | 0.080 |
Why?
|
Pyrrolidines | 1 | 2010 | 337 | 0.080 |
Why?
|
Transcription, Genetic | 2 | 2019 | 7599 | 0.080 |
Why?
|
Mitochondria | 1 | 2022 | 3673 | 0.080 |
Why?
|
Norepinephrine | 1 | 2010 | 900 | 0.070 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2010 | 412 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2017 | 11888 | 0.070 |
Why?
|
Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2006 | 29 | 0.070 |
Why?
|
Genotype | 1 | 2021 | 13024 | 0.070 |
Why?
|
Aminopyridines | 1 | 2010 | 576 | 0.070 |
Why?
|
Cerebral Cortex | 3 | 2017 | 5767 | 0.070 |
Why?
|
Protein Binding | 4 | 2012 | 9296 | 0.070 |
Why?
|
Neuralgia | 1 | 2013 | 625 | 0.060 |
Why?
|
Nucleus Accumbens | 3 | 2006 | 360 | 0.060 |
Why?
|
Cognition Disorders | 2 | 2021 | 3967 | 0.060 |
Why?
|
Sex Factors | 4 | 2024 | 10603 | 0.060 |
Why?
|
Serotonin | 1 | 2010 | 1049 | 0.060 |
Why?
|
Random Allocation | 1 | 2010 | 2395 | 0.060 |
Why?
|
Hypothalamus | 1 | 2010 | 993 | 0.060 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2010 | 1333 | 0.060 |
Why?
|
Nortriptyline | 1 | 2004 | 78 | 0.060 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 484 | 0.060 |
Why?
|
Corpus Striatum | 1 | 2010 | 1218 | 0.060 |
Why?
|
Bromodeoxyuridine | 1 | 2004 | 310 | 0.060 |
Why?
|
Lithium | 1 | 2007 | 597 | 0.060 |
Why?
|
Recreation | 1 | 2004 | 125 | 0.060 |
Why?
|
Mice, Inbred ICR | 2 | 2003 | 339 | 0.050 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2005 | 237 | 0.050 |
Why?
|
Antiparkinson Agents | 2 | 2018 | 185 | 0.050 |
Why?
|
Immunotherapy | 2 | 2021 | 4752 | 0.050 |
Why?
|
Models, Biological | 1 | 2019 | 9443 | 0.050 |
Why?
|
Antimanic Agents | 1 | 2007 | 523 | 0.050 |
Why?
|
Binding, Competitive | 3 | 2011 | 1140 | 0.050 |
Why?
|
Parkinson Disease | 1 | 2017 | 2895 | 0.050 |
Why?
|
Asphyxia | 1 | 2003 | 60 | 0.050 |
Why?
|
Neurons, Efferent | 1 | 2003 | 81 | 0.050 |
Why?
|
Pain Measurement | 3 | 2003 | 3561 | 0.050 |
Why?
|
Neuronal Plasticity | 2 | 2015 | 1445 | 0.050 |
Why?
|
Area Postrema | 1 | 2021 | 6 | 0.050 |
Why?
|
Electrical Synapses | 1 | 2022 | 18 | 0.050 |
Why?
|
Drug Design | 1 | 2007 | 1042 | 0.050 |
Why?
|
Gambling | 1 | 2004 | 180 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8626 | 0.050 |
Why?
|
Oncogene Protein v-akt | 1 | 2022 | 130 | 0.050 |
Why?
|
Circadian Rhythm | 2 | 2011 | 2592 | 0.050 |
Why?
|
Microsomes, Liver | 2 | 2012 | 174 | 0.050 |
Why?
|
Obesity | 1 | 2024 | 13076 | 0.050 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2009 | 1242 | 0.050 |
Why?
|
Arousal | 2 | 2000 | 1171 | 0.050 |
Why?
|
Gliosis | 2 | 2017 | 247 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2686 | 0.050 |
Why?
|
Female | 21 | 2024 | 396112 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2005 | 4392 | 0.040 |
Why?
|
Neuropeptides | 1 | 2006 | 951 | 0.040 |
Why?
|
Synaptic Vesicles | 1 | 2002 | 185 | 0.040 |
Why?
|
Genetics, Behavioral | 1 | 2000 | 52 | 0.040 |
Why?
|
Cell Count | 1 | 2004 | 1823 | 0.040 |
Why?
|
Hybridization, Genetic | 1 | 2000 | 102 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4850 | 0.040 |
Why?
|
Drug Interactions | 1 | 2004 | 1417 | 0.040 |
Why?
|
Prefrontal Cortex | 1 | 2010 | 2224 | 0.040 |
Why?
|
Cytoskeleton | 1 | 2005 | 1178 | 0.040 |
Why?
|
Habituation, Psychophysiologic | 1 | 2000 | 143 | 0.040 |
Why?
|
Carbon Dioxide | 1 | 2003 | 1137 | 0.040 |
Why?
|
Conditioning, Operant | 1 | 2000 | 306 | 0.040 |
Why?
|
Mice, Inbred Strains | 2 | 2000 | 1770 | 0.040 |
Why?
|
Mice, Inbred DBA | 1 | 2019 | 623 | 0.040 |
Why?
|
Exploratory Behavior | 2 | 2015 | 271 | 0.040 |
Why?
|
Neurotransmitter Agents | 1 | 2002 | 663 | 0.040 |
Why?
|
Adrenergic beta-1 Receptor Agonists | 1 | 2017 | 14 | 0.040 |
Why?
|
Receptor, Serotonin, 5-HT2B | 1 | 2017 | 6 | 0.040 |
Why?
|
Cocaine-Related Disorders | 1 | 2001 | 459 | 0.040 |
Why?
|
Levodopa | 1 | 2018 | 222 | 0.040 |
Why?
|
Memory Disorders | 1 | 2005 | 1194 | 0.040 |
Why?
|
Protons | 1 | 2023 | 1073 | 0.040 |
Why?
|
Urinary Bladder, Overactive | 1 | 2019 | 117 | 0.040 |
Why?
|
Endocytosis | 1 | 2002 | 951 | 0.040 |
Why?
|
Actins | 1 | 2005 | 2056 | 0.040 |
Why?
|
Self Administration | 2 | 2010 | 385 | 0.040 |
Why?
|
Behavior | 1 | 2000 | 535 | 0.030 |
Why?
|
Hyperkinesis | 1 | 2017 | 88 | 0.030 |
Why?
|
Signal Transduction | 5 | 2022 | 23601 | 0.030 |
Why?
|
Lod Score | 1 | 1997 | 598 | 0.030 |
Why?
|
Synapses | 2 | 2017 | 1754 | 0.030 |
Why?
|
Thalamus | 1 | 2003 | 1048 | 0.030 |
Why?
|
Humans | 22 | 2023 | 765968 | 0.030 |
Why?
|
Albuterol | 1 | 2017 | 211 | 0.030 |
Why?
|
Molecular Biology | 1 | 2000 | 574 | 0.030 |
Why?
|
Mice, Inbred C3H | 1 | 1997 | 914 | 0.030 |
Why?
|
Blood Proteins | 2 | 2012 | 1188 | 0.030 |
Why?
|
Protein Conformation | 2 | 2018 | 3946 | 0.030 |
Why?
|
Norway | 1 | 2017 | 499 | 0.030 |
Why?
|
Phagocytosis | 1 | 2022 | 1520 | 0.030 |
Why?
|
Propranolol | 1 | 2017 | 492 | 0.030 |
Why?
|
Synapsins | 1 | 2015 | 42 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2006 | 3690 | 0.030 |
Why?
|
Substantia Nigra | 1 | 2017 | 346 | 0.030 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2022 | 1140 | 0.030 |
Why?
|
Dyspnea | 1 | 2003 | 1352 | 0.030 |
Why?
|
HEK293 Cells | 2 | 2017 | 4260 | 0.030 |
Why?
|
Synaptophysin | 1 | 2015 | 137 | 0.030 |
Why?
|
Morphine Dependence | 1 | 1995 | 27 | 0.030 |
Why?
|
Solubility | 1 | 2017 | 1078 | 0.030 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2015 | 127 | 0.030 |
Why?
|
Immobilization | 1 | 1996 | 225 | 0.030 |
Why?
|
Neurogenesis | 1 | 2022 | 866 | 0.030 |
Why?
|
Drosophila Proteins | 1 | 2004 | 1697 | 0.030 |
Why?
|
Administration, Oral | 1 | 2003 | 4015 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1789 | 0.030 |
Why?
|
Eating | 1 | 2021 | 1540 | 0.030 |
Why?
|
Reaction Time | 3 | 2001 | 2086 | 0.030 |
Why?
|
Acetylation | 1 | 2017 | 1053 | 0.030 |
Why?
|
Quinolizines | 1 | 2014 | 20 | 0.030 |
Why?
|
Quantitative Trait, Heritable | 1 | 1997 | 541 | 0.030 |
Why?
|
Azocines | 1 | 2014 | 20 | 0.030 |
Why?
|
Chromosomes | 1 | 1997 | 578 | 0.030 |
Why?
|
Phenotype | 3 | 2021 | 16721 | 0.030 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2015 | 366 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2024 | 2796 | 0.030 |
Why?
|
Gene Deletion | 1 | 2021 | 2666 | 0.030 |
Why?
|
Learning | 2 | 2019 | 1755 | 0.030 |
Why?
|
Anilides | 1 | 2016 | 415 | 0.030 |
Why?
|
Alkaloids | 1 | 2014 | 190 | 0.030 |
Why?
|
Urinary Bladder | 1 | 2019 | 1154 | 0.030 |
Why?
|
Desipramine | 1 | 2013 | 183 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 1996 | 560 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2017 | 1077 | 0.030 |
Why?
|
Temperature | 1 | 2019 | 2226 | 0.030 |
Why?
|
Cell Line | 3 | 2012 | 15543 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2017 | 1130 | 0.020 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2012 | 72 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2020 | 1957 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1237 | 0.020 |
Why?
|
Receptors, Neurotransmitter | 1 | 2011 | 171 | 0.020 |
Why?
|
Genetic Markers | 1 | 1997 | 2601 | 0.020 |
Why?
|
Health Status | 1 | 2004 | 4080 | 0.020 |
Why?
|
Neural Pathways | 1 | 2002 | 3085 | 0.020 |
Why?
|
Protein Isoforms | 2 | 2009 | 1718 | 0.020 |
Why?
|
Mutation | 3 | 2024 | 30198 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11022 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2017 | 959 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2017 | 1365 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2022 | 2892 | 0.020 |
Why?
|
Molecular Conformation | 1 | 2012 | 541 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2016 | 938 | 0.020 |
Why?
|
Light | 1 | 2016 | 1365 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7202 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2017 | 2216 | 0.020 |
Why?
|
Astrocytes | 1 | 2017 | 1345 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2018 | 2589 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3584 | 0.020 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 2009 | 152 | 0.020 |
Why?
|
Cricetulus | 1 | 2010 | 805 | 0.020 |
Why?
|
Discrimination Learning | 1 | 2010 | 276 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7584 | 0.020 |
Why?
|
Age Factors | 3 | 2015 | 18380 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2015 | 1308 | 0.020 |
Why?
|
Prosencephalon | 1 | 2010 | 305 | 0.020 |
Why?
|
Treatment Failure | 1 | 2014 | 2652 | 0.020 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2009 | 164 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4528 | 0.020 |
Why?
|
Receptors, Opioid, mu | 1 | 2009 | 165 | 0.020 |
Why?
|
Chlordiazepoxide | 1 | 2007 | 42 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2012 | 1947 | 0.020 |
Why?
|
Histones | 1 | 2017 | 2584 | 0.020 |
Why?
|
Cricetinae | 1 | 2010 | 2411 | 0.020 |
Why?
|
Antigens, CD | 1 | 2017 | 4025 | 0.020 |
Why?
|
Receptors, Dopamine D2 | 1 | 2009 | 471 | 0.020 |
Why?
|
Mood Disorders | 1 | 2013 | 1128 | 0.020 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2006 | 141 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5786 | 0.020 |
Why?
|
Amphetamine | 1 | 2007 | 222 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2549 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9591 | 0.020 |
Why?
|
Mice, Neurologic Mutants | 1 | 2005 | 107 | 0.020 |
Why?
|
Receptors, AMPA | 1 | 2006 | 334 | 0.020 |
Why?
|
Genetic Variation | 1 | 2000 | 6610 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2001 | 3835 | 0.010 |
Why?
|
Bankruptcy | 1 | 2004 | 26 | 0.010 |
Why?
|
Pimozide | 1 | 2004 | 21 | 0.010 |
Why?
|
Patch-Clamp Techniques | 1 | 2006 | 918 | 0.010 |
Why?
|
Social Environment | 2 | 2000 | 1011 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2006 | 1083 | 0.010 |
Why?
|
Cotinine | 1 | 2004 | 206 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2822 | 0.010 |
Why?
|
Tetracycline | 1 | 2003 | 216 | 0.010 |
Why?
|
Dendrites | 1 | 2005 | 469 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7421 | 0.010 |
Why?
|
Pentylenetetrazole | 1 | 2002 | 72 | 0.010 |
Why?
|
Pyridinium Compounds | 1 | 2002 | 80 | 0.010 |
Why?
|
GABA Antagonists | 1 | 2002 | 120 | 0.010 |
Why?
|
Reward | 1 | 2009 | 981 | 0.010 |
Why?
|
Stress, Psychological | 1 | 1997 | 4533 | 0.010 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 2001 | 60 | 0.010 |
Why?
|
Cholinergic Fibers | 1 | 2001 | 68 | 0.010 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2002 | 204 | 0.010 |
Why?
|
Estrus | 1 | 2001 | 70 | 0.010 |
Why?
|
Presynaptic Terminals | 1 | 2003 | 297 | 0.010 |
Why?
|
Prisoners | 1 | 2004 | 316 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 17075 | 0.010 |
Why?
|
Clathrin | 1 | 2002 | 259 | 0.010 |
Why?
|
Transgenes | 1 | 2003 | 1015 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10850 | 0.010 |
Why?
|
Blotting, Western | 1 | 2006 | 5020 | 0.010 |
Why?
|
Acetylcholine | 1 | 2001 | 626 | 0.010 |
Why?
|
Electrophysiology | 1 | 2001 | 1263 | 0.010 |
Why?
|
Gyrus Cinguli | 1 | 2005 | 1117 | 0.010 |
Why?
|
Age Distribution | 1 | 2004 | 2858 | 0.010 |
Why?
|
Aged | 3 | 2021 | 171117 | 0.010 |
Why?
|
Age of Onset | 1 | 2004 | 3344 | 0.010 |
Why?
|
Cell Division | 1 | 2004 | 4475 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2004 | 2739 | 0.010 |
Why?
|
Cell Survival | 1 | 2006 | 5747 | 0.010 |
Why?
|
Point Mutation | 1 | 2001 | 1590 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2002 | 1180 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2006 | 2900 | 0.010 |
Why?
|
Species Specificity | 1 | 2000 | 2406 | 0.010 |
Why?
|
Calcium | 1 | 2009 | 5767 | 0.010 |
Why?
|
Phosphorylation | 1 | 2006 | 8278 | 0.010 |
Why?
|
Motivation | 1 | 2004 | 2018 | 0.010 |
Why?
|
Estrogens | 1 | 2001 | 1529 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 2009 | 2178 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 1930 | 0.010 |
Why?
|
Alcoholism | 1 | 2004 | 1975 | 0.010 |
Why?
|
Extinction, Psychological | 1 | 1996 | 367 | 0.010 |
Why?
|
Naloxone | 1 | 1995 | 373 | 0.010 |
Why?
|
Models, Neurological | 1 | 2000 | 1747 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2003 | 3607 | 0.010 |
Why?
|
Adolescent | 2 | 2013 | 88835 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 12768 | 0.010 |
Why?
|
Apoptosis | 1 | 2004 | 9514 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2013 | 59489 | 0.000 |
Why?
|
Survival Rate | 1 | 2002 | 12795 | 0.000 |
Why?
|
Young Adult | 1 | 2013 | 59889 | 0.000 |
Why?
|
Middle Aged | 2 | 2013 | 223009 | 0.000 |
Why?
|
Adult | 2 | 2013 | 223044 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2004 | 26318 | 0.000 |
Why?
|